X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
imidazolidines (401) 401
humans (384) 384
male (353) 353
imidazoles - therapeutic use (342) 342
animals (241) 241
aldehyde reductase - antagonists & inhibitors (167) 167
rats (146) 146
middle aged (143) 143
aged (137) 137
female (135) 135
imidazolidines - therapeutic use (114) 114
imidazoles - pharmacology (99) 99
prostatic neoplasms - drug therapy (99) 99
androgen antagonists - therapeutic use (90) 90
pharmacology & pharmacy (88) 88
angiotensin-converting enzyme inhibitors - therapeutic use (87) 87
adult (86) 86
double-blind method (82) 82
index medicus (81) 81
hydantoins (80) 80
diabetic neuropathies - drug therapy (70) 70
cardiac & cardiovascular systems (63) 63
anti-arrhythmia agents - therapeutic use (58) 58
imidazoles - adverse effects (58) 58
piperazines - therapeutic use (58) 58
imidazolidines - pharmacology (55) 55
sugar alcohol dehydrogenases - antagonists & inhibitors (55) 55
clinical trials as topic (52) 52
treatment outcome (52) 52
hypertension - drug therapy (49) 49
orchiectomy (46) 46
imidazoles - administration & dosage (44) 44
mice (44) 44
blood pressure - drug effects (42) 42
antineoplastic agents - therapeutic use (39) 39
flutamide - therapeutic use (39) 39
endocrinology & metabolism (38) 38
aged, 80 and over (36) 36
angiotensin-converting enzyme inhibitors - pharmacology (36) 36
rats, inbred strains (36) 36
imidapril (35) 35
diabetic neuropathies - physiopathology (34) 34
dogs (33) 33
dose-response relationship, drug (33) 33
enzyme inhibitors - therapeutic use (33) 33
prostate cancer (33) 33
aldose reductase (31) 31
antihypertensive agents - therapeutic use (31) 31
combined modality therapy (31) 31
peripheral vascular disease (31) 31
time factors (31) 31
urology & nephrology (31) 31
diabetes mellitus, experimental - drug therapy (30) 30
hypertension (30) 30
piperazines - pharmacology (29) 29
prostatic neoplasms - surgery (29) 29
diabetes (28) 28
diabetic retinopathy - drug therapy (28) 28
care and treatment (27) 27
sorbitol - metabolism (27) 27
aldehyde reductase - metabolism (26) 26
anilides - therapeutic use (26) 26
anti-arrhythmia agents - pharmacology (26) 26
flutamide (26) 26
nitriles (26) 26
prostatic neoplasms - pathology (26) 26
rats, sprague-dawley (26) 26
arrhythmias, cardiac - drug therapy (25) 25
diabetes mellitus, experimental - physiopathology (25) 25
prostatic neoplasms - blood (25) 25
prostatic neoplasms - therapy (25) 25
analysis (24) 24
diabetes mellitus, experimental - complications (24) 24
follow-up studies (24) 24
imidazoles - pharmacokinetics (24) 24
prospective studies (24) 24
tosyl compounds (24) 24
disease models, animal (23) 23
neural conduction - drug effects (23) 23
random allocation (23) 23
antineoplastic agents, hormonal - therapeutic use (22) 22
azimilide (22) 22
heart rate - drug effects (22) 22
hypertension - physiopathology (22) 22
medicine & public health (22) 22
aldose reductase inhibitor (21) 21
carcinoma (21) 21
imidazolidines - chemistry (21) 21
myocardial-infarction (21) 21
oxidative stress (21) 21
prostatic neoplasms - mortality (21) 21
randomized controlled trials as topic (21) 21
sorbinil (21) 21
diabetes mellitus, experimental - metabolism (20) 20
medicine, general & internal (20) 20
oncology (20) 20
prostate-specific antigen - blood (20) 20
structure-activity relationship (20) 20
survival rate (20) 20
adolescent (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (516) 516
Japanese (18) 18
French (16) 16
German (7) 7
Chinese (3) 3
Russian (2) 2
Danish (1) 1
Hebrew (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 10/2017, Volume 117, Issue 8, pp. 1233 - 1240
Background: As androgen deprivation therapy (ADT) is increasingly being used in men with localised prostate cancer, our goal was to examine the association... 
androgen deprivation therapy | MORTALITY | cardiovascular disease | METAANALYSIS | DEATH | SUPPRESSION | TRIAL | prostate cancer | ONCOLOGY | MEN | TESTOSTERONE DEFICIENCY | RADIOTHERAPY | CORONARY-HEART-DISEASE | DURATION | Multivariate Analysis | Anilides - therapeutic use | Prospective Studies | Humans | Middle Aged | Male | Neoplasm Grading | Antineoplastic Agents, Hormonal - therapeutic use | Cardiovascular Diseases - epidemiology | Flutamide - therapeutic use | Goserelin - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Heart Failure - epidemiology | Prostatic Neoplasms - drug therapy | Arrhythmias, Cardiac - epidemiology | Prostatic Neoplasms - pathology | California - epidemiology | Risk Factors | Proportional Hazards Models | Imidazolidines - therapeutic use | Prostatic Neoplasms - epidemiology | Tosyl Compounds - therapeutic use | Leuprolide - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Cohort Studies | Nitriles - therapeutic use | Heart failure | Heart | Drugs | Therapy | Conduction | Deprivation | Arrhythmia | Risk groups | Health risks | Cardiovascular disease | Risk analysis | Minority & ethnic groups | Patients | Risk factors | Surveillance | Failure analysis | Men | Cardiovascular diseases | Health risk assessment | Prostate cancer | Heart diseases | Prostate | Cancer | Tumors | Epidemiology
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 167 - 15
Journal Article
Cancer, ISSN 0008-543X, 06/2008, Volume 112, Issue 11, pp. 2393 - 2400
Journal Article
Cancer Research, ISSN 0008-5472, 02/2012, Volume 72, Issue 4, pp. 969 - 978
Journal Article
FASEB Journal, ISSN 0892-6638, 09/2011, Volume 25, Issue 9, pp. 2911 - 2920
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 02/2015, Volume 64, Issue 2, pp. 643 - 653
We previously showed that peripheral neuropathy of the bone marrow was associated with loss of circadian rhythmicity of stem/progenitor cell release into the... 
NERVE-CONDUCTION | NADPH OXIDASE | OXIDATIVE STRESS | ENDOTHELIAL DYSFUNCTION | TYROSINE-HYDROXYLASE | NITRIC-OXIDE SYNTHASE | HEMATOPOIETIC STEM-CELLS | ENDOCRINOLOGY & METABOLISM | ALDOSE REDUCTASE INHIBITION | ALPHA-LIPOIC ACID | ADIPOSE-TISSUE | Adipose Tissue - physiology | Membrane Glycoproteins - metabolism | Streptozocin | NADPH Oxidases - metabolism | Male | RNA, Messenger - metabolism | Tyrosine 3-Monooxygenase | Diabetes Mellitus, Experimental - therapy | Fish Oils - therapeutic use | Stem Cells | Hypoglycemic Agents - administration & dosage | NADPH Oxidases - genetics | Fish Oils - administration & dosage | Somatostatin | Cytokines - genetics | Hypoglycemic Agents - therapeutic use | Neuropeptide Y | Cytokines - metabolism | Diabetic Neuropathies - prevention & control | RNA, Messenger - genetics | Gene Expression Regulation | Rats | Insulin - administration & dosage | Imidazolidines - therapeutic use | NADPH Oxidase 2 | Rats, Sprague-Dawley | Membrane Glycoproteins - genetics | Animals | Nitric Oxide Synthase Type II - genetics | Bone Marrow - pathology | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - therapeutic use | Inflammation - prevention & control | Pain Measurement | Insulin - therapeutic use | Nitric Oxide Synthase Type II - metabolism | Thioctic Acid - therapeutic use | Genetically modified mice | Circadian rhythms | Care and treatment | Analysis | Bone marrow | Dosage and administration | Research | Diseases | Complications
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2008, Volume 102, Issue 6, pp. 12H - 19H
Journal Article
Clinical & Experimental Ophthalmology, ISSN 1442-6404, 09/2007, Volume 35, Issue 7, pp. 664 - 671
The incidence of cataract continues to increase with the ageing of the population. Surgical treatment with phacoemulsification and intraocular lens... 
clinical trial | pathogenesis | medical treatment | cataract | blindness | Clinical trial | Cataract | Pathogenesis | Medical treatment | Blindness | HUMAN LENS | VITAMIN-E | RISK-FACTORS | CLINICAL-TRIAL | BENDAZAC LYSINE | DIABETIC RATS | SENILE CATARACT | OPHTHALMOLOGY | L-LYSINE SALT | AGE-RELATED CATARACT | ALDOSE REDUCTASE | Analgesics - therapeutic use | Aldehyde Reductase - antagonists & inhibitors | Diabetes Complications | Cataract - etiology | Humans | Carnosine - therapeutic use | Vitamins - therapeutic use | Enzyme Inhibitors - therapeutic use | Ophthalmology - methods | Carnosine - analogs & derivatives | Ophthalmology - trends | Sunlight - adverse effects | Animals | Aging | Cataract - drug therapy | Calpain - antagonists & inhibitors | Indazoles - therapeutic use | Carnosine, therapeutic use | Oxidative Stress | Aldehyde Reductase, antagonists and inhibitors | Aspirin, therapeutic use | Calpain, metabolism | Cataract, epidemiology | Calpain, antagonists and inhibitors | Lens, Crystalline, radiation effects | Dipeptides, therapeutic use | Carnosine, metabolism | Carnosine, analogs and derivatives | Lens, Crystalline, metabolism | Acetaminophen, therapeutic use | Cataract, drug therapy | Diabetes Mellitus, complications | Ascorbic Acid, therapeutic use | Visual Acuity | Aldehyde Reductase, metabolism | Vitamin E, therapeutic use | Cataract, metabolism | Sunlight | Imidazolidines, therapeutic use | Ibuprofen, therapeutic use | Lipid Peroxidation | Dietary Supplements | Knowledge-based systems
Journal Article
Journal Article
Heart, ISSN 1355-6037, 03/2011, Volume 97, Issue 6, pp. 479 - 484
BackgroundAnti-angiotensin II receptor subtype 1 (AT1 receptor) autoantibodies have previously been shown in sera of hypertensive patients. This study assessed... 
AT-RECEPTOR | CARDIAC & CARDIOVASCULAR SYSTEMS | IMMUNE-SYSTEM | AT RECEPTOR | AGONISTIC ANTIBODIES | MALIGNANT HYPERTENSION | PEPTIDE | Double-Blind Method | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Autoantibodies - blood | Humans | Middle Aged | Hypertension - drug therapy | Male | Treatment Outcome | Hypertension - immunology | Imidazolidines - therapeutic use | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Imidazolidines - adverse effects | Adult | Female | Tetrazoles - therapeutic use | Aged | Blood Pressure - drug effects | Receptor, Angiotensin, Type 1 - immunology | Tetrazoles - adverse effects | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Hypertension | Autoantibodies | Candesartan | Dosage and administration | Research | Drug therapy | ACE inhibitors | Cardiovascular disease | Heart attacks | Kinases | Colleges & universities | Blood Pressure | Benzimidazoles | Dermatologi och venereologi | Dermatology and Venereal Diseases | Tetrazoles | Mikrobiologi inom det medicinska området | Angiotensin II Type 1 Receptor Blockers | Antihypertensive Agents | immunology | Type 1 | drug therapy | drug effects | blood | Imidazolidines | physiopathology | Microbiology in the medical area | Receptor | Angiotensin | adverse effects | therapeutic use
Journal Article
Journal Article